• Biotech Is The New Digital Says MIT Media Lab Founder

    Apr 25, 2017, 12:39 PM by Michael Croft
    Dezeen | Biotechnology is going to "govern the next decade of thought" at research institutions like the MIT Media Lab, says its founder Nicholas Negroponte.
    Full story

  • Recipharm appoints Henrik Stenqvist as new Chief Financial Officer

    Apr 25, 2017, 09:57 AM by Michael Croft
    STOCKHOLM, SWEDEN - Apr 11, 2017 - Recipharm AB today announced the appointment of Henrik Stenqvist as Recipharm’s new Executive Vice President and Chief Financial Officer, effective on April 24, 2017
    Full story

  • DNA Tests and Sometimes Surprising Results

    Apr 24, 2017, 10:40 AM by Michael Croft
    The New York Times | Think you know your racial background? A communications studies project involving ancestry DNA testing has led to interesting conversations on identity.
    Full story

  • Hannes Smarason On The Future Of The Platform For WuXi NextCODE

    Apr 24, 2017, 10:10 AM by Michael Croft
    Diagnostics World | Hannes Smarason, WuXi NextCode's new CEO, is looking to enable the use of the WuXi NextCode platform across a multitude of applications. The goal is to create a Contract Genomics Organization, an underlying platform for genomic data that brings together everything needed to empower healthcare.
    Full story

  • Biogen Says Its Back and Ready for ‘Highly Active’ Dealmaking

    Apr 24, 2017, 09:42 AM by Michael Croft
    Bloomberg | Biogen Inc. is ready to make some deals. "We're moving, and we're back in terms of augmenting the pipeline," research and development head Michael Ehlers said Friday in an interview. An agreement last week to pay Bristol-Myers Squibb Co. $300 million upfront for an experimental Alzheimer's drug is "hopefully just the beginning of a set of very rigorous but highly active deals."
    Full story

  • Recipharm opens new GMP suite for clinical trial material

    Apr 24, 2017, 09:26 AM by Michael Croft
    NORTH CAROLINA, NC - Apr 24, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina, USA
    Full story

  • Recipharm delivers first serialised batch to Saudi Arabia

    Apr 21, 2017, 11:50 AM by Michael Croft
    LISBON, PORTUGAL - Apr 21, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has delivered its first batch of serialised drug products to Saudi Arabia, following the introduction of new regulatory requirements in March 2017
    Full story

  • World’s largest society for regulatory professionals increases investment in Europe

    Apr 21, 2017, 10:46 AM by Michael Croft
    - Apr 20, 2017 - The Regulatory Affairs Professionals Society (RAPS) is stepping up its presence in Europe and expanding its European team in response to growing membership demand from those involved with the regulation of healthcare and related products
    Full story

  • The Go-To Gene Sequencing Machine With Very Strange Results

    Apr 21, 2017, 10:31 AM by Michael Croft
    WIRED | An update to Illumina's gene sequencing technology could have contaminated the results of recent high-sensitivity data produced on the machines.
    Full story

  • Geisinger Accused Of Coercing Patients To Participate In Genetic Research

    Apr 20, 2017, 14:57 PM by Michael Croft
    PennLive.com | The Geisinger Health System has been accused by two of its former doctors of coercing patients to participate in genetic research. The accusation was made in a wrongful termination suit filed this week.
    Full story

  • Certara Introduces Comprehensive Solution to Prepare, Analyze and Submit Pharmacokinetic (PK) Data

    Apr 20, 2017, 09:43 AM by Michael Croft
    PRINCETON, NJ - Apr 19, 2017 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the launch of a new solution for preparing, analyzing and submitting PK data in Clinical Data Exchange Standards Consortium (CDISC) format
    Full story

  • Google Offshoot Starts A 10000-Person Study To Plumb Human Biology

    Apr 20, 2017, 09:09 AM by Michael Croft
    Forbes | Verily, formerly known as Google Life Sciences, is launching a long-awaited study whose methods may offer a realistic blueprint for how tech could change medicine. But it's also an emblem of how long that transformation will take.
    Full story

  • Building BioTeam’s Texas Sandbox

    Apr 19, 2017, 10:35 AM by Michael Croft

    Bio-IT World | In 2015, Ari Berman, BioTeam’s Vice President and General Manager of Consulting Services decided that the consultancy needed a better spot for non-digital products. BioTeam launched its Convergence Lab, datacenter space hosted by the Texas Advanced Computing Center in Austin, Texas, dedicated to BioTeam. Now with a maturing business model, the Convergence Lab is beginning to play host to some of BioTeam's best ideas. 

    Full story

  • Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street

    Apr 18, 2017, 10:32 AM by Michael Croft
    Xconomy | Research Triangle Park, NC-based G1 has filed for an initial public offering that could raise up to $115 million. G1 has yet to work out the number of shares it will offer and at what price.
    Full story

  • Geneious Biologics Set to Launch at Bio-IT World

    Apr 18, 2017, 00:25 AM by Michael Croft
    AUCKLAND, NEW ZEALAND - Apr 18, 2017 - Geneious Biologics, a next-generation cloud service developed to empower enterprises engaged in commercial antibody discovery and screening and significantly improve their success rates, will launch at Bio-IT World Conference & Expo, in Boston MA, on May 23, 2017
    Full story

  • Bio-IT World Announces Finalists For Best Practices Awards

    Apr 14, 2017, 08:30 AM by Michael Croft

    Bio-IT World | The finalists for the 2017 Bio-IT World Best Practices competition have been announced. This year, 23 projects from 36 different groups were chosen for the final round of competition.

    Full story

  • NantOmics Acquires Genos

    Apr 13, 2017, 16:20 PM by Michael Croft
    Bio-IT World Brief  NantOmics today announced its acquisition of Genos, a consumer genomics startup that launched its services last year.
    Full story

  • Building And Supporting Mobile Apps In The Cloud

    Apr 13, 2017, 15:25 PM by Michael Croft
    Bio-IT World | Bio-IT World Expo Commentary  Mobile application development is a term used to denote the act or process by which application software is developed for mobile devices and it is growing steadily and at a rapid pace. With the increase in the usage of cloud technology, mobile development is the need of the hour. Most of the major products now have mobile modules attached and sometimes even provided as incentive to increase their sales. Mobile development has also brought changes to project management methodology in organizations. Cohesiveness and synergy between various teams is now more visible than ever.
    Full story

  • CRISPR Cousin SHERLOCK May Be Able To Track Down Diseases, Scientists Say

    Apr 13, 2017, 14:46 PM by Michael Croft
    STAT | Scientists have found a way to use CRISPR to develop quick, easy, cheap, and precise diagnostic tests, including in the field during a disease outbreak.
    Full story

  • Berkeley Lab Supercomputer Breaks New Ground In Quantum Computing Simulation

    Apr 13, 2017, 12:46 PM by Michael Croft
    TOP500 | Cori, the fifth fastest supercomputer in the world, has been used to model a 45-qubit circuit, which, by all accounts, is the largest simulation of a quantum computer ever achieved. The virtual circuit is just a handful of qubits short of a quantum computing system that would be more powerful than any conventional computer currently devised.
    Full story